
Monti Plus®
Therapeutic Segment:
Antiallergic
Generic Name:
Montelukast Sodium + Levocetirizine Dihydrochloride
Indication
Tablet
- 10MG/5MG
Monti Plus (Montelukast Sodium + Levocetirizine Dihydrochloride) is indicated for:
Relief of symptoms of (seasonal or perennial) allergic rhinitis. Prophylaxis in seasonal allergic rhinitis. Treatment of Comorbid asthma & allergic rhinitis in patients 15 years of age and over.